Nanotechnology offers new ways to redesign platinum cancer drugs

Nanotechnology offers new ways to redesign platinum cancer drugs
Image: Intellect (generated)

In short: A review of platinum-based cancer treatments explains how drugs such as cisplatin, carboplatin and oxaliplatin are widely used but limited by toxicity and drug resistance. The authors describe how advances in nanotechnology are producing redesigned platinum compounds, including tiny platinum nanoclusters that act through different biological pathways and have shown encouraging results in early clinical use.

The review traces the development of first-line platinum chemotherapies and the biology behind them, then surveys newer nanodrug strategies designed to sharpen tumour targeting and ease side effects.

As a literature review, it summarises existing research rather than presenting new experiments, and the authors note that real challenges remain before nanocluster-based platinum drugs become established cancer treatments.

Why it matters: Nanotechnology-redesigned platinum drugs may one day reduce the toxicity and resistance problems of standard chemotherapy.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/technology-research-new-platinum-based-nanodrugs-may-improve-the-precision-of-ca.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…